A Clustering Framework for Patient Phenotyping with Application to Adverse Drug Events

We present a clustering framework for identifying patient groups with Adverse Drug Reactions from Electronic Health Records (EHRs). The increased adoption of EHRs has brought changes in the way drug safety surveillance is carried out and plays an important role in effective drug regulation. Unsuperv...

Full description

Saved in:
Bibliographic Details
Published in2020 IEEE 33rd International Symposium on Computer-Based Medical Systems (CBMS) pp. 177 - 182
Main Authors Bampa, Maria, Papapetrou, Panagiotis, Hollmen, Jaakko
Format Conference Proceeding
LanguageEnglish
Published IEEE 01.07.2020
SeriesIEEE International Symposium on Computer-Based Medical Systems
Subjects
Online AccessGet full text
ISBN172819430X
9781728194295
1728194296
9781728194301
ISSN2372-9198
DOI10.1109/CBMS49503.2020.00041

Cover

More Information
Summary:We present a clustering framework for identifying patient groups with Adverse Drug Reactions from Electronic Health Records (EHRs). The increased adoption of EHRs has brought changes in the way drug safety surveillance is carried out and plays an important role in effective drug regulation. Unsupervised machine learning methods using EHRs as their input can identify patients that share common meaningful information, without the need for expert input. In this work, we propose a generalized framework that exploits the strengths of different clustering algorithms and via clustering aggregation identifies consensus patient cluster profiles. Moreover, the inherent hierarchical structure of diagnoses and medication codes is exploited. We assess the statistical significance of the produced clusterings by applying a randomization technique that keeps the data distribution margins fixed, as we are interested in evaluating information that is not conveyed by the marginal distributions. The experimental findings suggest that the framework produces medically meaningful patient groups with regard to adverse drug events by investigating two use-cases, i.e., aplastic anaemia and drug-induced skin eruption.
ISBN:172819430X
9781728194295
1728194296
9781728194301
ISSN:2372-9198
DOI:10.1109/CBMS49503.2020.00041